MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. (Q34120830)

31 July 2017

title

MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. (English)

1 reference

31 July 2017

Ling Ding

1 reference

31 July 2017

Yanjun Xu

1 reference

31 July 2017

Wei Zhang

1 reference

31 July 2017

Yujie Deng

1 reference

31 July 2017

Misi Si

1 reference

31 July 2017

Ying Du

1 reference

31 July 2017

Haomi Yao

1 reference

31 July 2017

Xuyan Liu

1 reference

31 July 2017

Yuehai Ke

1 reference

31 July 2017

Jianmin Si

1 reference

31 July 2017

Tianhua Zhou

1 reference

31 July 2017

publication date

15 June 2010

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

784-793

1 reference

The functions of animal microRNAs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNAs: a developing story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Role of miRNA in carcinogenesis and biomarker selection: a methodological view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Gene deregulation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Decreased expression of microRNA-143 and -145 in human gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Down-regulated miR-9 and miR-433 in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Detection of miR-106a in gastric carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

miR-375 maintains normal pancreatic alpha- and beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Mining for JAK-STAT mutations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Absence of JAK2 V617F mutation in gastric cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Kinase drug discovery approaches in chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

A mammalian NudC-like protein essential for dynein stability and cell viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

Inhibition of cytokinesis by overexpression of NudCL that is localized to the centrosome and midbody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Down-regulation of miR-141 in gastric cancer and its involvement in cell growth

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.79

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CR.2010.79

1 reference

Dimensions Publication ID

31 July 2017

1003569803

0 references

1 reference